Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Iteos Therapeutics Inc ITOS

Healthcare Biotechnology
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ITOS)

iTeos to Participate in Upcoming Investor Conferences

GlobeNewswire 3 days ago

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire November 12, 2024

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

GlobeNewswire October 24, 2024

iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

GlobeNewswire September 14, 2024

iTeos to Participate in Upcoming Investor Conferences

GlobeNewswire August 28, 2024

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

GlobeNewswire August 20, 2024

iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire August 8, 2024

iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer

GlobeNewswire August 5, 2024

iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK

GlobeNewswire July 8, 2024
View More News ››

Opinion & Analysis (NDAQ:ITOS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ITOS)

Overweight Recommendation Issued On ITOS By Piper Sandler

News; $ITOS Overweight Recommendation Issued On ITOS By Piper Sandler2024-09-16 09:30:10 ET Piper Sandler analyst issues OVERWEIGHT...
whytestocks - September 16, 2024

iTeos Therapeutics Announces Late-Breaking Oral Presentation

BREAKING NEWS: $ITOS iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the...
whytestocks - August 20, 2024

iTeos Therapeutics Announces $120 Million Registered Direct

Just In: $ITOS iTeos Therapeutics Announces $120 Million Registered Direct Offering- Led by existing investors RA Capital Management and...
whytestocks - May 10, 2024
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »